65 related articles for article (PubMed ID: 12046338)
1. [DNA methylation as an etiologic factor in carcinogenesis].
Zaletaev DV; Nemtsova MV; Bochkov NP
Vestn Ross Akad Med Nauk; 2002; (4):6-11. PubMed ID: 12046338
[TBL] [Abstract][Full Text] [Related]
2. [Promoter hypermethylation and CpG island methylator phenotype in colorectal carcinogenesis].
Matsubara N
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1659-64. PubMed ID: 20841928
[TBL] [Abstract][Full Text] [Related]
3. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis.
Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y
Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156
[TBL] [Abstract][Full Text] [Related]
4. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
5. WT1 CpG islands methylation in human lung cancer: a pilot study.
Bruno P; Gentile G; Mancini R; De Vitis C; Esposito MC; Scozzi D; Mastrangelo M; Ricci A; Mohsen I; Ciliberto G; Simmaco M; Mariotta S
Biochem Biophys Res Commun; 2012 Sep; 426(3):306-9. PubMed ID: 22925896
[TBL] [Abstract][Full Text] [Related]
6. Methylation of miRNA genes and oncogenesis.
Loginov VI; Rykov SV; Fridman MV; Braga EA
Biochemistry (Mosc); 2015 Feb; 80(2):145-62. PubMed ID: 25756530
[TBL] [Abstract][Full Text] [Related]
7. CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene.
Schroeder M; Mass MJ
Biochem Biophys Res Commun; 1997 Jun; 235(2):403-6. PubMed ID: 9199206
[TBL] [Abstract][Full Text] [Related]
8. Assessment of global and gene-specific DNA methylation in rat liver and kidney in response to non-genotoxic carcinogen exposure.
Ozden S; Turgut Kara N; Sezerman OU; Durasi İM; Chen T; Demirel G; Alpertunga B; Chipman JK; Mally A
Toxicol Appl Pharmacol; 2015 Dec; 289(2):203-12. PubMed ID: 26431795
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
10. [Global DNA hipomethylation--the meaning in carcinogenesis].
Guz J; Foksiński M; Oliński R
Postepy Biochem; 2010; 56(1):16-21. PubMed ID: 20499677
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
12. Silencing of bidirectional promoters by DNA methylation in tumorigenesis.
Shu J; Jelinek J; Chang H; Shen L; Qin T; Chung W; Oki Y; Issa JP
Cancer Res; 2006 May; 66(10):5077-84. PubMed ID: 16707430
[TBL] [Abstract][Full Text] [Related]
13. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
14. CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis.
Joo MK; Kim KH; Park JJ; Yoo HS; Choe J; Kim HJ; Lee BJ; Kim JS; Bak YT
Mol Med Rep; 2015 Apr; 11(4):3039-46. PubMed ID: 25483734
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide screening of aberrant DNA methylation which associated with gene expression in mouse skin cancers.
Fujiwara K; Ghosh S; Liang P; Morien E; Soma M; Nagase H
Mol Carcinog; 2015 Mar; 54(3):178-88. PubMed ID: 24115114
[TBL] [Abstract][Full Text] [Related]
17. Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis.
Tahara T; Arisawa T; Shibata T; Yamashita H; Yoshioka D; Hirata I
Anticancer Res; 2009 Jan; 29(1):337-41. PubMed ID: 19331170
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation and epigenetic mechanisms of carcinogenesis.
Baylin S
Dev Biol (Basel); 2001; 106():85-7; discussion 143-60. PubMed ID: 11761271
[No Abstract] [Full Text] [Related]
19. CpG-island methylation in aging and cancer.
Issa JP
Curr Top Microbiol Immunol; 2000; 249():101-18. PubMed ID: 10802941
[No Abstract] [Full Text] [Related]
20. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]